Healthcare and Pharmaceuticals industry

Global Naloxone Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Naloxone is an opioid antagonist used to counter the effects of opioid overdose, such as morphine and heroine. Naloxone is indicated for use in opioid overdose to counteract life-threatening depression of the central nervous system and respiratory system, allowing an overdose victim to breathe normally. Naloxone is non-scheduled prescription medication, which in most cases, is administrated by emergency response personnel or minimally trained personnel, and is thus ideal for treating overdose in people who are prescribed opioid pain medication. Naloxone can be administrated through parenteral route, by injecting in the muscle or vein.
Market Dynamics
Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October, 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada
Rising prevalence of opioid overdose in key regions such as North America, and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.
Furthermore, initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.
Key features of the study:

This report provides in-depth analysis of naloxone market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global naloxone market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global naloxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the naloxone market

Detailed Segmentation:

Global Naloxone Market, By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

Global Naloxone Market, By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

Global Naloxone Market, By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

Global Naloxone Market, By Geography:

North America

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

U.S.
Canada


Europe

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe


Asia Pacific

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific


Latin America

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America


Middle East

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

GCC
Israel
Rest of Middle East


Africa

By Strength:

0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others

By Drug Type:

Intranasal
Intramuscular/Subcutaneous
Intravenous

By Distribution Channel:

Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

By Country:

Central Africa
South Africa
North Africa



Company Profiles

Mylan N.V.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Novartis AG
Indivior Plc.
Adapt Pharma, Inc.
Amphastar Pharmaceuticals, Inc.
INSYS Therapeutics, Inc.
Mundipharma International Limited
Kaleo, Inc.
Kern Pharma, S.L.


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Strength
o Market Snippet, By Route of Administration
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Product Approvals/Launch
o Pipeline Analysis
o Regulatory Scenario
o Reimbursement Scenario
o Dosage Variation
o Pricing Analysis
o Supply Chain Analysis
4. Global Naloxone Market, By Strength, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o 0.4 mg/ml
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o 1mg/ml
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o 0.4mg/0.4ml
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o 4mg/0.1ml and Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
5. Global Naloxone Market, By Route of Administration, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Intranasal
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Intramuscular/Subcutaneous
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Intravenous
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
6. Global Naloxone Market, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Clinics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
7. Global Naloxone Market, By Region, 2016 - 2026 (US$ Mn)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
o Market Size and Forecast, By Strength, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
o GCC
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Mylan N.V.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Novartis AG
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Indivior Plc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Adapt Pharma, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Amphastar Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o INSYS Therapeutics, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Mundipharma International Limited
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Kaleo, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Kern Pharma, S.L.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 47 market data tables and 33 figures on "Naloxone Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.